Mineralocorticoid receptor mediates heart failure in the 11ß-hydroxysteroid dehydrogenase type 2 transgenic mouse model

被引：0
作者：
Qin, WN
Bond, BR
Donoho, GP
Heyen, JR
Frierdich, GE
Bolten, CW
Funder, JW
McMahon, EG
机构：
[1] Pfizer Inc, Groton, CT 06340 USA
[2] Pfizer Inc, St Louis, MO USA
[3] Pfizer Inc, Kalamazoo, MI USA
[4] Pfizer Inc, La Jolla, CA USA
[5] Prince Henrys Inst Med Res, Melbourne, Vic, Australia
来源：
CIRCULATION | 2004年 / 110卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2946
引用
收藏
页码：634 / 634
页数：1
相关论文
共 50 条
[31]   Expression of the 11β-hydroxysteroid dehydrogenase 2 gene in the mouse [J].
Moore, XL ;
Hoong, I ;
Cole, TJ .
KIDNEY INTERNATIONAL, 2000, 57 (04) :1307-1312
[32]   Localisation of 11-Hydroxysteroid Dehydrogenase Type 2 in Mineralocorticoid Receptor Expressing Magnocellular Neurosecretory Neurones of the Rat Supraoptic and Paraventricular Nuclei [J].
Haque, M. ;
Wilson, R. ;
Sharma, K. ;
Mills, N. J. ;
Teruyama, R. .
JOURNAL OF NEUROENDOCRINOLOGY, 2015, 27 (11) :835-849
[33]   Coexpression of mineralocorticoid receptors and 11β-hydroxysteroid dehydrogenase 2 in human gastric mucosa [J].
Kato, K ;
Sasano, H ;
Ohara, S ;
Sekine, H ;
Mochizuki, S ;
Mune, T ;
Yasuda, K ;
Nagura, H ;
Shimosegawa, T ;
Toyota, T ;
Krozowski, Z .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (07) :2568-2573
[34]   Coexpression of mineralocorticoid receptors and 11β-hydroxysteroid dehydrogenase 2 in human gastric mucosa [J].
Kato, K ;
Sasano, H ;
Mochizuki, S ;
Arikawa, T ;
Kubota, Y ;
Noguchi, K ;
Suzuki, T ;
Sekine, H ;
Ohara, S ;
Asaki, S ;
Shimosegawa, T ;
Toyota, T .
GASTROENTEROLOGY, 1999, 116 (04) :A434-A434
[35]   Ectopic lipid deposition mediates insulin resistance in adipose specific 11β -hydroxysteroid dehydrogenase type 1 transgenic mice [J].
Abulizi, Abudukadier ;
Camporez, Joao-Paulo ;
Zhang, Dongyan ;
Samuel, Varman T. ;
Shulman, Gerald, I ;
Vatner, Daniel F. .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2019, 93 :1-9
[36]   Inactivation of glucocorticoids in osteoblasts by targeted overexpression of 11β-hydroxysteroid dehydrogenase type 2 in transgenic mice [J].
Woitge, HW ;
Kalajzic, I ;
Clark, SH ;
Gronowicz, G ;
Krozowski, Z ;
Harrison, JR ;
Kream, BE .
BONE, 2001, 28 (05) :S75-S75
[37]   11β-hydroxysteroid dehydrogenase type 2 in mouse aorta -: Localization and influence on response to glucocorticoids [J].
Christy, C ;
Hadoke, PWF ;
Paterson, JM ;
Mullins, JJ ;
Seckl, JR ;
Walker, BR .
HYPERTENSION, 2003, 42 (04) :580-587
[38]   THE MINERALOCORTICOID RECEPTOR DISCRIMINATES ALDOSTERONE FROM GLUCOCORTICOIDS INDEPENDENTLY OF THE 11-BETA-HYDROXYSTEROID DEHYDROGENASE [J].
LOMBES, M ;
KENOUCH, S ;
SOUQUE, A ;
FARMAN, N ;
RAFESTINOBLIN, ME .
ENDOCRINOLOGY, 1994, 135 (03) :834-840
[39]   The codon 213 of the 11β-hydroxysteroid dehydrogenase type 2 gene is a hot spot for mutations in apparent mineralocorticoid excess [J].
Rogoff, D ;
Smolenicka, Z ;
Bergadá, I ;
Vallejo, G ;
Barontini, M ;
Heinrich, JJ ;
Ferrari, P .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (12) :4391-4393
[40]   A new compound heterozygous mutation in the 11β-hydroxysteroid dehydrogenase type 2 gene in a case of apparent mineralocorticoid excess [J].
Kitanaka, S ;
Katsumata, N ;
Tanae, A ;
Hibi, I ;
Takeyama, KI ;
Fuse, H ;
Kato, S ;
Tanaka, T .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (12) :4054-4058
12345